入驻_老虎社区_美港股上老虎

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":12865,"tweetId":"12865","gmtCreate":1461028513177,"gmtModify":1704871039327,"author":{"id":54659087570754,"authorId":54659087570754,"authorIdStr":"54659087570754","name":"日积月累","avatar":"https://static.laohu8.com/tiger_upload_file_1452270171.png","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"入驻","extraTitle":"","html":"<html><head></head><body><p>$Viking Therapeutics, Inc.(VKTX)$这股有关注的吗？小仓位进来看看</p></body></html>","htmlText":"<html><head></head><body><p>$Viking Therapeutics, Inc.(VKTX)$这股有关注的吗？小仓位进来看看</p></body></html>","text":"$Viking Therapeutics, Inc.(VKTX)$这股有关注的吗？小仓位进来看看","highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/12865","repostId":0,"isVote":1,"tweetType":1,"viewCount":1007,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["VKTX"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":60,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":131083,"gmtCreate":1461063761523,"gmtModify":1461063761523,"authorId":92530329323271,"author":{"id":92530329323271,"authorId":92530329323271,"name":"T92530329323271","avatar":"https://static.laohu8.com/tiger_upload_file_1456919059.png","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":12865,"type":1,"supId":0,"prevId":0,"content":"我做的有这股","text":"我做的有这股","html":"我做的有这股","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

入驻

评论（1）

热议股票